Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Equity Ratio (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Equity Ratio for 15 consecutive years, with 0.12 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 56.02% to 0.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.12 through Dec 2025, down 56.02% year-over-year, with the annual reading at 0.15 for FY2025, 34.92% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.12 at Aytu Biopharma, down from 0.19 in the prior quarter.
  • The five-year high for Equity Ratio was 0.52 in Q2 2021, with the low at 0.12 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.29, with a median of 0.28 recorded in 2023.
  • The sharpest move saw Equity Ratio surged 155.64% in 2021, then crashed 56.02% in 2025.
  • Over 5 years, Equity Ratio stood at 0.47 in 2021, then plummeted by 31.3% to 0.32 in 2022, then fell by 22.73% to 0.25 in 2023, then increased by 5.75% to 0.26 in 2024, then plummeted by 56.02% to 0.12 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.12, 0.19, and 0.15 for Q4 2025, Q3 2025, and Q2 2025 respectively.